| |
| |
|
|
R E S O L U T I O N
|
|
|
WHEREAS, Dr. Jennifer Keating Litton of The University of |
|
|
Texas MD Anderson Cancer Center in Houston has distinguished |
|
|
herself through her many contributions to cancer research and |
|
|
treatment; and |
|
|
WHEREAS, Over the course of her tenure at MD Anderson, Dr. |
|
|
Litton has held numerous leadership positions, including chief of |
|
|
the Section of Clinical Research and Drug Development in the |
|
|
Department of Breast Medical Oncology, where she also served as an |
|
|
associate professor; she has also spearheaded the Breast Medical |
|
|
Oncology Education Program, the Scientific Review Research |
|
|
Committee, and the Genitourinary Chair Search Committee; she |
|
|
currently serves as vice president of clinical research, leading |
|
|
the largest cancer clinical trials program in the country with more |
|
|
than 1,500 clinical trials and over 10,000 patients enrolled in |
|
|
therapeutic trials; moreover, she is a member of the faculty at the |
|
|
UTHealth Houston Graduate School of Biomedical Sciences at MD |
|
|
Anderson; and |
|
|
WHEREAS, Dr. Litton has been involved in numerous committees |
|
|
and organizations, including the Society for Immunotherapy of |
|
|
Cancer, the American Society of Clinical Oncology, the Society of |
|
|
Surgical Oncology, the American Society for Radiation Oncology, the |
|
|
FORCE Advisory Board, the Clinical Cancer Genetics Steering |
|
|
Committee, and Living Beyond Breast Cancer; she is also a member of |
|
|
Suites of Hope in Houston and the Texas Lyceum in Austin; in 2018, |
|
|
she received the President's Recognition of Faculty Excellence |
|
|
Award in Prevention Outreach from MD Anderson; and |
|
|
WHEREAS, Board certified in oncology and internal medicine, |
|
|
Dr. Litton focuses her research on pregnancy and breast cancer, |
|
|
genetic testing, and molecular changes of breast cancer genes; she |
|
|
holds a bachelor's degree from Duke University, a doctor of |
|
|
medicine degree from the University of Massachusetts Medical |
|
|
School, and a master's degree in health care management from the |
|
|
Harvard T. H. Chan School of Public Health; she completed her |
|
|
residency and chief residency at the Baylor College of Medicine as |
|
|
well as a fellowship in medical oncology at MD Anderson; and |
|
|
WHEREAS, Through her leadership, skill, and commitment to |
|
|
excellence, Dr. Litton has made a lasting and positive impact in her |
|
|
field, and it is a privilege to join in recognizing this outstanding |
|
|
professional; now, therefore, be it |
|
|
RESOLVED, That the House of Representatives of the 89th Texas |
|
|
Legislature hereby honor Dr. Jennifer Keating Litton for her many |
|
|
professional achievements and extend to her sincere best wishes for |
|
|
continued success; and, be it further |
|
|
RESOLVED, That an official copy of this resolution be |
|
|
prepared for Dr. Litton as an expression of high regard by the Texas |
|
|
House of Representatives. |